Aesthetic manufacturer mesoestetic has announced the launch of c.prof mesoxome, the latest addition to its microneedling solution range.
According to the company, the new line is powered by proprietary mesoxome technology, combining specialised exosomes with targeted actions and polydeoxyribonucleotide (PDRN)polynucleotides to support regenerative and reparative processes.
mesoestetic explains that the indication-specific solutions are designed for professional use with devices and transepidermal administration systems. The company further reports that efficacy is supported by in vitro, ex vivo and in vivo studies, demonstrating outcomes related to skin regeneration, repair and revitalisation.
Stephen Schofield, commercial director at mesoestetic UK, commented, “At mesoestetic, innovation and clinical efficacy are at the heart of everything we do. The introduction of c.prof mesoxome range represents a significant advancement in professional microneedling solutions, combining next-generation mesoxome exosome technology with regenerative PDRN and active ingredients to deliver targeted, high-performance results.”